SCHEMBL7147848

SCHEMBL7147848

CCOC(=O)CC(CCCCNC(=O)c1sc(NC(=N)N)nc1C)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
LMNA P02545 2/20 0.53
KDM4E B2RXH2 3/20 0.49
NPSR1 Q6W5P4 2/20 0.49
RXFP1 Q9HBX9 1/20 0.49
RAB9A P51151 4/20 0.48
NPC1 O15118 3/20 0.48
PKM P14618 2/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
F2 P00734 2/20 0.47
SMN1; SMN2 Q16637 4/20 0.45
CSNK1D P48730 2/20 0.44
F10 P00742 2/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 2/20 0.42
HPGD P15428 2/20 0.42
KIFC1 Q9BW19 1/20 0.42
ITGB3 P05106 1/20 0.42
ITGA2B P08514 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7140672 0.90 ITGB3 (0.51) ALDH1A1LMNAKDM4ENPSR1RXFP1
SCHEMBL7140676 0.90 ITGB3 (0.51) ALDH1A1LMNAKDM4ENPSR1RXFP1
SCHEMBL7141440 0.86 LCK (0.54) ALDH1A1LMNAKDM4ENPSR1RXFP1
SCHEMBL7143985 0.84 ALDH1A1 (0.51) ALDH1A1LMNAKDM4ENPSR1RXFP1
SCHEMBL7145110 0.83 F2 (0.46) ALDH1A1LMNAKDM4ERAB9ANPC1
Acetone SCHEMBL7140518 0.82 ALDH1A1 (0.49) ALDH1A1LMNAKDM4ENPSR1RXFP1
Hydrochloric Acid SCHEMBL8067753 0.81 ALDH1A1 (0.56) ALDH1A1LMNAKDM4ENPSR1RXFP1
Ethyl Acetate SCHEMBL7141371 0.78 KIFC1 (0.46) ALDH1A1LMNAKDM4ENPSR1RXFP1
SCHEMBL7137175 0.76 LCK (0.58) ALDH1A1LMNARAB9ANPC1MEN1
SCHEMBL7137170 0.76 LCK (0.58) ALDH1A1LMNARAB9ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6100282-A Thiazole derivatives HOFFMAN-LA ROCHE INC. (US) 2000-08-08 US claimed
EP-0928790-B1 Thiazole derivatives HOFFMANN LA ROCHE (CH) 2003-03-05 EP disclosed
US-6344562-B1 ANTITUMOR AGENTS HOFFMANN-LA ROCHE INC. 2002-02-05 US disclosed
US-20020010316-A1 Thiazole derivatives ALIG LEO (CH) 2002-01-24 US disclosed
US-6320054-B1 INHIBIT BINDING OF ADHESIVE PROTEINS TO THE SURFACE OF DIFFERENT TYPES F CELL AND ACCORDINGLY INFLUENCE CELL-CELL AND CELL-MATRIX INTERACTIONS. HOFFMAN-LA ROCHE INC. 2001-11-20 US disclosed
US-6100282-A Thiazole derivatives HOFFMAN-LA ROCHE INC. (US) 2000-08-08 US disclosed
EP-0928790-A1 Thiazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 1999-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010316-A1 Thiazole derivatives VCAM1, SOST, TGFB1 ALDH1A1 1400/4885LMNA 3184/4885KDM4E 4278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.